Filing Details
- Accession Number:
- 0001181431-13-039223
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-08 20:23:03
- Reporting Period:
- 2013-07-03
- Filing Date:
- 2013-07-08
- Accepted Time:
- 2013-07-08 20:23:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1285819 | Omeros Corp | OMER | Pharmaceutical Preparations (2834) | 911663741 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472158 | J. Thomas Cable | 201 Elliott Avenue West Seattle WA 98119 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-07-03 | 5,000 | $5.21 | 77,067 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Open market sale pursuant to a 10b5-1 trading plan adopted by the reporting person on July 3, 2012, at which time the trading schedule and the number of shares to be sold was established, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $5.13 to $5.28; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
Billionaire Hedge Funds
